Oyama, Y., Bartman, C. M., Gile, J., Sehrt, D., & Eckle, T. (2018). The circadian PER2 enhancer Nobiletin reverses the deleterious effects of midazolam in myocardial ischemia and reperfusion injury. Curr Pharm Des.

Oyama, Yoshimasa, Colleen Marie Bartman, Jennifer Gile, Daniel Sehrt, ja Tobias Eckle. "The Circadian PER2 Enhancer Nobiletin Reverses the Deleterious Effects of Midazolam in Myocardial Ischemia and Reperfusion Injury." Curr Pharm Des 2018.

Oyama, Yoshimasa, et al. "The Circadian PER2 Enhancer Nobiletin Reverses the Deleterious Effects of Midazolam in Myocardial Ischemia and Reperfusion Injury." Curr Pharm Des 2018.